Treatment with Dgat1-ASO inhibits the activation of HSCs in mice and rats, increases the expression of LRAT, promotes the accumulation of RE in the liver, and alleviates liver fibrosis (Yamaguchi et al., 2008). The gene discussed is DGAT1; the disease is Hepatic fibrosis.